ProMIS Neurosciences, Inc. (PMN) Press Releases

Get updates from ProMIS Neurosciences, Inc. (PMN) Press Releases via email, on your phone or read them on follow.it on your own custom news page.

You can filter the news from ProMIS Neurosciences, Inc. (PMN) Press Releases that get delivered to you using tags or topics or you can opt for all of them. Unsubscription is also very simple.

See the latest news from ProMIS Neurosciences, Inc. (PMN) Press Releases below.

Site title: ProMIS Neurosciences, Inc. (PMN)

Is this your feed? Claim it!

Publisher: Unclaimed!

Message frequency: 0.07 / day

Message History

Targeting underlying causes of neurodegenerative diseases | 2026 Bloom Burton & Co. Healthcare Investor Conference3 days

2026 Bloom Burton & Co. Healthcare Investor Conference
"Targeting underlying causes of neurodegenerative diseases"
Presented by Neil K. Warma
CEO, ProMIS Neurosciences

Presented on 4/21/2026

Read full story

ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights1 month

Read full story

BriefGlance.com: ProMIS Unveils Precision Vaccines for ALS and Parkinson's Disease1 month

Read full story

ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease...1 month

Read full story

ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 20263 months

Cambridge, Massachusetts, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders, today announced the company will be participating in a fireside chat and investor one-on-one meetings at the Guggenheim...

Read full story

Login to follow.it

Keep me logged in

Or:

Don't have an account yet?

ProMIS Neurosciences, Inc. (PMN) Press Releases

Message History

Delivery option(s)